Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs

BSE3926.4514.55 (+0.37 %)

PREV CLOSE ( ) 3911.90

OPEN PRICE ( ) 3900.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3481

TODAY'S LOW / HIGH ( )3860.05 3938.40

52 WK LOW / HIGH ( )3050.15 4104

NSE3929.0018.25 (+0.47 %)

PREV CLOSE( ) 3910.75

OPEN PRICE ( ) 3887.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 3929.00 (155)

VOLUME 31964

TODAY'S LOW / HIGH( ) 3870.00 3965.00

52 WK LOW / HIGH ( )3051 4100

Quarters

Select year

( in Million)

Particulars

Dec 2023

Sep 2023

Jun 2023

Mar 2023

Audited / UnAudited

UnAudited

Audited

Net Sales

18550

19090

17780

19507.7

Total Expenditure

13660

14300

12740

14631.8

PBIDT (Excl OI)

4890

4790

5040

4875.9

Other Income

950

860

810

661.5

Operating Profit

5840

5650

5850

5537.4

Interest

2.4

Exceptional Items

PBDT

5840

5640

5850

5535

Depreciation

950

930

870.2

Profit Before Tax

4890

4690

4920

4664.8

Tax

1310

1210

1360

1455.1

Provisions and contingencies

Profit After Tax

3580

3480

3560

3209.7

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

3580

3480

3560

3209.7

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

3580

3480

3560

3209.7

Equity Capital

530

530.9

Face Value (IN RS)

Reserves

Calculated EPS

13.50

13.13

13.43

12.09

Calculated EPS (Annualised)

54.03

52.52

53.73

48.36

No of Public Share Holdings

127626980

127611980

127585380

% of Public Share Holdings

48.08

48.07

48.06

PBIDTM% (Excl OI)

26.36

25.09

28.34

24.99

PBIDTM%

31.48

29.59

32.90

28.38

PBDTM%

31.48

29.54

32.90

28.37

PBTM%

26.36

24.56

27.67

23.91

PATM%

19.29

18.22

20.02

16.45

Notes

Risk Disclosures on Derivatives

Quarterly Results

DIVI'S LABORATORIES LTD.